Seqirus Presentation to Investors/Analysts

Seqirus Presentation to Investors/Analysts

Melbourne, Australia — 14/03/2016

This presentation to investors/analysts was given by:

  • Gordon Naylor, President, Seqirus
  • Russell Basser, SVP R&D, Seqirus
  • Brent MacGregor, SVP Commercial Operations, Seqirus
during a site tour of the Seqirus influenza vaccine manufacturing facility at Liverpool, England on Friday, 11 March 2016. An investor/analyst visit to the Seqirus influenza vaccine manufacturing facility at Holly Springs, USA also took place on Monday, 14 March 2016.

Download the presentation: 
PDF icon Seqirus Presentation to Investors/Analysts during site tours in Liverpool, England and Holly Springs, USA  (1.8Mb)


© 2017 CSL Limited